2026 Congress
Private Course
Please sign in
| Last Update | 12/02/2026 |
|---|---|
| Completion Time | 1 month 3 weeks 3 days 16 hours 1 minute |
| Members | 4 |
-
Congress photos2Lessons ·
-
Photos - ThursdayNew
-
Photos - FridayNew
-
-
Book of Abstracts1Lessons ·
-
Book of abstractsNew
-
-
S1 - YCC: Invisible Killers: Pollution, Noise & Climate Stress on the Heart3Lessons · 2 days 22 hrs 21 mins
-
1 - Fine Dust, Big Impact: Air Pollution as a Leading Heart Risk FactorNew
-
2 - Noisy World, Silent Killer: How Noise Drives Cardiovascular DiseaseNew
-
3 - Rising heat, Risking Risk: Climate Change and Cardiovascular MortalityNew
-
-
S2 - Radiation2Lessons · 2 days 18 hrs 51 mins
-
1 - Chest Radiation: New Frontiers in CardioprotectionNew
-
2 - Personal Radiation Protection Equipment (PRPE): Good Practice and Material Insights from PhD ResearchNew
-
-
S4 - Keynote: Improving Cardiovascular Health In The EU: The Challenges Ahead2Lessons · 2 days 1 hr 54 mins
-
1 - Keynote presentationNew
-
2 - Gold medal presentationNew
-
-
S6 - BACTS/BSC joint session: The tricuspid valve: how to manage it right?3Lessons · 3 days 11 hrs 34 mins
-
1 - Tricuspid valve evaluation through multimodality imaging: what do the guidelines tell us?New
-
2 - Tricuspid valve surgery : how to proceed and why?New
-
3 - Transcatheter treatment for tricuspid valve disease – will the cardiologist replace the cardiac surgeon?New
-
-
S7 - Scientific symposium sponsored by AstraZeneca: Belgian Initiatives in Cardiovascular Care to improve the Journey of Patients with Heart Failure, Hypertension, and Cardiac Amyloidosis3Lessons · 2 days 14 hrs 40 mins
-
1 - Implementation of AI into clinical practice: early detection and prevention of cardiovascular diseasesNew
-
2 - Closing the Diagnostic Gap in HFpEF: A Structured Dyspnea Clinic ApproachNew
-
3 - Resistant Hypertension Work-UpNew
-
-
S9 - BeHRA: Idiopathic VF: need for standardization4Lessons · 3 days 1 hr 15 mins
-
1 - SCD in Europe: where does Belgium stand?New
-
2 - Clinical care pathway for idiopathic VFNew
-
3 - Genetic aspects of idiopathic VFNew
-
4 - Best abstract, Influence of Self-reported Training Load and Exercise Modality on Atrial Fibrillation Prevalence in Middle-Aged MalesNew
-
-
S10 - Scientific symposium sponsored by Alnylam: A new chapter in ATTR-CM: what comes next in clinical practice?4Lessons · 3 days 33 mins
-
1 - The unmet needNew
-
2 - The treatmentNew
-
3 - The patientNew
-
4 - Discussions and Q&ANew
-
-
S12 - BWGA: Artificial Intelligence and cardiovascular diseases4Lessons · 2 days 19 hrs 13 mins
-
1 - AI for dummies: view from a cardiologistNew
-
2 - AI and vascular diseasesNew
-
3 - AI and pulmonary embolismNew
-
4 - Q&ANew
-
-
S13 - Scientific symposium sponsored by BMS - Cardiovascular care and prevention through an economic lens: optimizing oHCM via early search, detection, treatment, and structured care4Lessons · 2 days 14 hrs 13 mins
-
1 - Keynote: The Health Economics of Cardiovascular DiseasesNew
-
2 - Clinical Talk: Detect to protectNew
-
3 - Clinical Practice, Genetic Testing in HCM: From Diagnosis to Family CareNew
-
4 - Clinical Practice, Six Pillars for a structured HCM ClinicNew
-
-
S15 - BWGHF: Heart Failure in Women5Lessons · 2 days 20 hrs 54 mins
-
1 - Best Abstract, Characterization of atrial function in pulmonary vascular diseasesNew
-
2 - Run the world : Sex related differences in Heart Failure (risk factors, diagnosis, HF phenotypes)New
-
3 - More than a woman : Heart Failure in women : Age and Hormonal influencesNew
-
4 - Respect : Is Heart Failure treatment different in women ?New
-
5 - Q&A and discussionNew
-
-
S16 - Scientific symposium sponsored by MSD: Next-Gen Therapies in Cardiology: from Sotatercept to the Future of Lipid Management3Lessons · 2 days 16 hrs 35 mins
-
1 - Sotatercept: A New Chapter in PH CareNew
-
2 - Eradicating LDL-C related risk: What’s in the pipeline?New
-
3 - DiscussionNew
-
-
S18 - BWGIC Filling the gap between treatment guidelines and current practice in Belgium4Lessons · 3 days 1 hr 4 mins
-
1 - Transcatheter aortic valve implantation for aortic stenosis: the elephant in the roomNew
-
2 - Remaining structural challenges: fact or fiction?New
-
3 - Coronary imaging and intervention: an evolving landscapeNew
-
4 - Best abstract, Rapid atrial pacing as a predictor of permanent pacemaker implantation post-TAVI: the PACE TAVI studyNew
-
-
S19 - Scientific symposium sponsored by Eli Lilly - Tirzepatide and the Cardiologist: A New Chapter in Cardiometabolic Risk Management3Lessons · 2 days 20 hrs 25 mins
-
1 - Obesity as a Cardiometabolic Catalyst: Mechanisms, Consequences and Therapeutic InnovationNew
-
2 - Beyond Glycemic Control: Tirzepatide’s potential in Cardiovascular Care for Type 2 DiabetesNew
-
3 - Panel Discussion “From Evidence to Action: Incretins in Belgian Cardiometabolic Practice"New
-
-
S21 - BWGPC and Belgian Heart Ligue6Lessons · 2 days 20 hrs 59 mins
-
1 - "Caught in the Middle": Strategies and tools for assessing Cardiovascular RiskNew
-
2 - The new kid on the block – Lipoprotein(a)New
-
3 - Coronary calcium score and CT-angiography: Tools for Cardiovasculair risk (re)stratificationNew
-
4 - The Digital Shift in Cardiovascular Prevention: Tools, Trends, and TomorrowNew
-
5 - Panel discussion and Q and ANew
-
6 - Best abstract, From SCORE-Belgium to SCORE2: opposite reclassification trends in 2019, 2021, and 2025 risk classification updatesNew
-
-
S22 - Scientific symposium sponsored by Bayer: Beyonttra: A new chapter in ATTR-CM management3Lessons · 2 days 17 hrs 26 mins
-
1 - Beyonttra (acoramidis), a new chapter in ATTR-CM managementNew
-
2 - Beyonttra - next step in amyloidosis treatment TTR stabilization: a cornerstone in ATTR treatmentNew
-
3 - Cardiac Amyloidosis: Tackling some Clinical ProblemsNew
-
-
S24 - ESC/BSC Joint session: 2025 ESC/EACTS Guidelines for the management of valvular heart diseaseheart disease (Joint Guidelines with EACTS)1Lessons · 1 day 3 hrs 48 mins
-
1 - Valvular heart disease (Joint Guidelines with EACTS)New
-
-
S25 - Cardiogenomics How to interpret a genetic report and manage the result?4Lessons · 2 days 12 hrs 26 mins
-
1 - The evolving landscape of variant classificationNew
-
2 - Genetic counselling: when, how and why should I report the results? Define the concept of actionability and situations like cascade screening and prenatal/PGDNew
-
3 - Could a genetic result influence my global cardiovascular risk for coronary artery disease? discuss part of heritability in cardiovascular risk ex Lpa - FH - PRSNew
-
4 - The case of incidental findings: what should I do with an unexpected result?New
-
-
S26 - Scientific symposium sponsored by Novo Nordisk - Beyond Metabolic Control: Incretin Mimetics as Gamechangers in Cardiometabolic Inflammation and CV Risk5Lessons · 3 days 3 hrs 49 mins
-
5 - Best abstract, Telomere length in patients with Marfan syndrome: a pilot studyNew
-
1 - From Weight Loss to Event Reduction: SELECT’s Implications for ASCVD ManagementNew
-
2 - Obesity-related HFpEF: Pathophysiology and Therapeutic OpportunitiesNew
-
3 - Breaking the T2D–CKD–CVD Cycle: Therapeutic Strategies and Emerging EvidenceNew
-
4 - Panel discussion and closure by ChairsNew
-
-
S28 - BIWAC Mechanical complications after ACS: a multidisciplinary approach1Lessons · 2 days 6 hrs 22 mins
-
1 - Mechanical complications after ACS: a multidisciplinary approach A case-based session where the following topics will be covered: ventricular septal rupture, aute papillary muscle rupture, indications for temporary mechanical circulatory supportNew
-
-
S29 - BWGNICI Imaging in inflammatory myopericardial syndrome: update from the 2025 Guidelines4Lessons · 3 days 3 hrs 39 mins
-
1 - Best abstract, Non-invasive left ventricle strain-volume-pressure loops in asymptomatic significant aortic regurgitation: the potential to further enhance the prediction of the onset of aortic valve surgery indicationNew
-
2 - Recurrent pericarditis: role of cardiac imagingNew
-
3 - Multimodality imaging in myocardial inflammationNew
-
4 - Sport resumption after acute myocarditisNew
-